National Institutes of Health (NIH) — 2016 Investments
305 investments dated 2016 · page 2 of 2 · listed companies and verified rows first · show all
HealthtechMadison, US
Carl Gulbrandsen(Director)Benjamin Titz(Executive Officer, Director)Kevin W. Eliceiri(Director)Thomas R. Mackie(Executive Officer, Director)Adam J. Uselmann(Executive Officer, Director)Andreas Velten(Director)
Two Pore Guys is a diagnostics company developing a handheld nanopore-based analyte sensor for point-of-care testing, with applications including liquid biopsy cancer detection.
BiotechDeep TechDigital HealthHardwareMedical DevicesSanta Cruz, US
Co-investorsKhosla VenturesDEFTA Partners
A care coordination platform that connects patients' behavioral and physical health data across providers, health plans, and government agencies, delivering real-time alerts, controlled substance data, and analytics inside clinical workflows.
AI & Machine LearningDigital HealthHealthtech
Opticent Health develops Aurora X4, a free-standing OCT imaging platform for clinical research of the human eye that combines hardware and software with advanced features like pupil monitoring and NIR scanning laser ophthalmoscopy for patient alignment and imaging.
AI & Machine LearningBiotechHealthtechMedical Devices
Influents Innovations (Or-Bis) develops evidence-based programs and digital products that apply behavioral research and technology to challenges in health care, social services, and education, addressing areas such as perinatal depression, early literacy, oral health, and youth tobacco prevention.
Digital HealthEdTechHealthtech
Organix provides custom synthesis, drug delivery, polymer chemistry, and analytical services for biotech, pharmaceutical, and materials science companies.
BiotechDeep TechEnterprise SoftwareNew MaterialsWoburn, US
Anu Mahadevan(CEO)Paul Blundell(President)
Oricula Therapeutics develops small-molecule therapeutics for hearing loss and ototoxicity prevention, with a focus on aminoglycoside antibiotic-induced hearing damage.
BiotechHealthtechMedical DevicesSeattle, US
Edwin W. Rubel, PhD(University of Washington, Chaired Professor)David W. Raible, PhD(University of Washington, Professor)Julian Simon, PhD(Affiliate Associate Professor, University of Washington)
Origent develops predictive analytics and AI platforms for drug development and patient empowerment, helping pharmaceutical sponsors reduce clinical trial risk through patient-level forecasting and narrative health data capture.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
OtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type.
AI & Machine LearningDigital HealthHardwareHealthtechMedical DevicesSeattle, US
Caitlin Cameron(Chair & CEO)in
Co-investorsGolden SeedsCatalytic Impact FoundationDellin InvestmentsFarvatn VentureKeiretsu ForumMindshift Capital+6 more
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Matt Angle(Founder and CEO)inRon Kelly(Director)Thomas Krummel(Director)Adam Kablanian(Director)
Co-investors15th RockAlpha EdisonAnthropy PartnersATEL VenturesCapital FactoryCloudStone Capital+28 more
PetxLLC develops advanced PET/CT imaging systems and high-resolution medical imaging equipment for clinical and preclinical applications.
Deep TechHardwareHealthtechMedical DevicesSeattle, US
Paul E. Kinahan(co-Founder, VP of Research)Lawrence R. Macdonald(co-Founder)William Hunter(CEO, CSO)
BiotechChestnut Hill, US
Joseph Italiano(Director)inJonathan Thon(Director)Sven Erik Karlsson(Executive Officer)Peter Finn(Executive Officer)
Co-investorsBoston Harbor AngelsQiming HealthcareThird Rock VenturesVivo Capital
BiotechWoburn, US
Ian Magazine(Executive Officer)James Coull(Executive Officer, Director)Bruce Armitage(Executive Officer, Director)
BoardJoseph Walton(Director)
Potomac Affinity Proteins develops protein-based engineered products and technologies derived from NIH-funded research for biomedical and diagnostic applications.
BiotechDeep TechMedical DevicesCollege Park, US
Philip N. Bryan(Founder and Scientific Director)
Proportional Technologies develops neutron detection systems using boron-coated straw (BCS) technology as a replacement for expensive helium-3 detectors, serving security, nuclear weapons detection, and scientific research applications.
Deep TechDefense TechHardwareAngleton, US
Jeffrey L. Lacy(Founder, Ph.D.)
BiotechSyracuse, US
Richard Uhlig(Executive Officer, Director)Erica Ash(Executive Officer)James Croke(Executive Officer, Director)Richard Bongo(Executive Officer, Director)inNicholas Gianadda(Executive Officer)Bryan Greene(Executive Officer)in
Resodyn Corporation is a research and development company that engineers and manufactures technology products and provides engineering and manufacturing services, developing solutions through public grants (such as SBIR) and private R&D contracts.
Advanced ManufacturingDeep TechHardware
HealthtechSan Francisco, US
Reza Naima(Executive Officer, Director)
Co-investorsEmergent Medical Partners, LLPKeshif VenturesLaunchCapitalLaunch CapitalNorwich Ventures
BiotechNew York, US
Masoud Tavazoie(Chief Scientific Officer)David Darst(Chief Operating Officer)Isabel Kurth(Vice President - Research)
BoardShahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)
Co-investors+ND CapitalOceanpine CapitalSofinnova Partners
BiotechBoston, US
William Adams(Executive Officer, Director)Michael Serrano-Wu(Director)
Rubitection develops the Rubitect Assessment System for early detection and management of pressure injuries (bedsores) in healthcare settings.
AI & Machine LearningHealthtechMedical DevicesRochester, US
Sanna Gaspard(CEO)
BoardJosh Ghaims(Technology Advisor)in
Salus Discovery develops molecular diagnostics technologies, including passive sample pre-concentration (Flow) that boosts lateral-flow assay sensitivity and rapid analyte extraction, concentration, and purification methods (ESP) for sample preparation.
BiotechDeep TechMedical DevicesMadison, US
Sano Chemicals is a clinical-stage drug development company creating new chemical entities (NCEs) as first-in-class treatments for antimicrobial-resistant fungi and bacteria, with additional research into cancer applications.
BiotechHealthtechLongevityMedical DevicesBryan, US
James Leif Smith(Executive Officer)
Sedia manufactures laboratory-based assays for detecting recent HIV-1 infections, enabling public health monitoring and outbreak surveillance in high-risk regions.
BiotechDigital HealthHealthtechMedical DevicesBeaverton, US
Roger Gale(Founder)Ronald Mink(Founder)
BiotechCharlestown, US
Eric Stern(Executive Officer, Director, Promoter)Aleksandar Vacic(Executive Officer, Promoter)inJames Parker Cassidy(Director)Scott Yaphe(Director)Steven E. Lufkin(Executive Officer, Director)Michael Rubin(Director)
Co-investorsRA CapitalSands Capital Ventures
BiotechGoleta, US
Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)inNick Naclerio(Director)inJohn Shon(Executive Officer)
Co-investorsIllumina InnovationIllumina Ventures
SILCS is computational chemistry software that maps functional group affinities across protein surfaces to guide drug design.
AI & Machine LearningBiotechDeep Tech
Kelsey Abernathy(Chief Executive Officer)Olgun Guvench(Managing Partner)Alexander MacKerell(Chief Science Officer)
Simphotek Medical Devices develops light-based cancer treatment planning software using photodynamic therapy dosimetry to guide physicians in administering personalized light and drug therapies.
Deep TechHealthtechMedical DevicesBuffalo, US
Gene Parilov(Co-founder and CTO)Mary Potasek(Co-founder and CSO)Karl Beeson(Co-founder and VP of Technology)
SiMPore develops silicon nanomembrane technology products for biomedical research, environmental analysis, and materials science applications.
BiotechDeep TechHardwareNew MaterialsRochester, US
James Roussie(Chief Scientific Officer & Co-Founder)James McGrath(Corporate Director & Co-founder)Thomas Gaborski(Corporate Director & Co-founder)
QuartzBio provides a conversational AI platform that enables clinical-stage biopharma teams to gain real-time insights from fragmented sample, clinical, and biomarker data across their entire lifecycle.
AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtech
Co-investorsNat Turner
SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners.
Deep TechHealthtechMedical DevicesSan Mateo, US
Oren Levy(Chief Executive Officer, Co-Founder)inPaul Douglas Corl(Executive Officer)Doug Corl(Chief Technology Officer)Michael Bailey(Executive Officer, Director)Barbrina Dunmire(Director)
Co-investorsBioventures Investors
Co-investorsElevate Ventures
Spectral Energies develops advanced laser and propulsion technologies for the aerospace, defense, transportation, and energy sectors, drawing on extensive research and government contracts with agencies including DoD, NASA, and DoE.
Deep TechDefense TechEnergyHardwareBeavercreek, US
Sukesh Roy(CEO)Sivaram P. Gogineni(President)Mitch Icard(COO)
HealthtechLafayette, US
Brian Kopp(Executive Officer, Promoter)inSteve Mogensen(Executive Officer, Director, Promoter)in
Co-investorsElevate Ventures
Speragen is a biotech company founded to address the challenges faced by patients with rare genetic disorders, specifically SSADH deficiency, by accelerating the development and availability of therapies.
Biotech
A mother of two children affected with SSADH deficiency
Spheryx develops Total Holographic Characterization technology for analyzing suspensions at the sub-visible particle level, including detecting protein aggregates and particles in biopharmaceuticals.
BiotechDeep TechHardwareNew York, US
Laura Philips(Executive Officer, Director)inDavid Grier(Director)
BiotechSan Clemente, US
Derek Herrera(Executive Officer, Director)Christopher Jennings(Director)Bill Colone(Executive Officer, Director)Kenneth Baker(Director)
Co-investorsParticular VenturesStorm Industries InvestmentsSv Tech Ventures, Inc.
STARGATES is an engineering and technology company providing systems integration, cybersecurity, and software development services to federal and defense agencies as well as Fortune 500 companies.
CybersecurityDeep TechDefense TechEnterprise SoftwareArlington, US
Starship Health develops software frameworks and tools for behavioral public health, including local social-network smartphone apps, virtual role-playing tutors for communication skills training, and analytical tools for mapping and diagnosing care coordination cases.
AI & Machine LearningDigital HealthEdTechHealthtech
StemMed provides patient-derived xenograft (PDX) models and related research materials for cancer research, serving biomedical researchers conducting studies at their own facilities.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Dr. Tweardy(Head of the Division of Internal Medicine, Professor of Infectious Diseases and Molecular & Cellular Oncology)Michael Lewis(Associate Professor in the Departments of Molecular and Cellular Biology and Radiology)
Sunnylife Pharma develops pharmaceuticals to address unmet medical needs in disease treatment, founded by former Merck scientists and collaborating with industry and academic partners globally.
BiotechHealthtechMedical DevicesNorth Brunswick, US
Veteran Merck scientists (group)
Swallow Solutions develops products for people with dysphagia (difficulty swallowing), offering specially formulated beverages and desserts to meet hydration and nutrition needs and reduce choking risk, as well as medical devices for oropharyngeal strengthening therapy.
FoodTechHealthtechMedical DevicesMadison, US
JoAnne Robbins, Ph.D.(Director)Robert A. Carlson, M.D.(Executive Officer)Eric H. Horler(Executive Officer, Director)Raymond Heller(Executive Officer)
BoardThomas G. Schuster(Director)Terence F. Kelly(Director)
Sylvatica Bio develops organ and tissue preservation technologies, including supercooling methods that extend the viability of human organs such as livers outside the body.
BiotechDeep TechMedical Devices
Sebastian Eriksson Giwa, PhD(Founder)inMike Taylor(Founder)in
Co-investorsStartXTaihill Venture
Synvivia engineers molecules designed to reprogram cells.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Gabriel Lopez(CEO)in
Co-investorsCAL InnovationCalifornia Innovation FundCreative VenturesGaingelsMetaplanetThundermark Capital+5 more
Shasqi is a biotech company developing pre-targeted cancer therapeutics using click chemistry to direct cancer drugs to tumors, aiming to improve efficacy while reducing dose-limiting toxicities.
BiotechHealthtechSan Francisco, US
José M. Mejía Oneto(CEO & Founder)
BiotechBranford, US
John Richard Nobile(Executive Officer, Director, Promoter)John Davidson(Executive Officer, Director, Promoter)
Co-investorsFreemind InvestmentsConnecticut InnovationsLeading Edge Ventures
Reading Plus is an adaptive literacy instruction platform for schools that improves reading comprehension, fluency, and motivation through assessment-driven instruction grounded in decades of reading research.
EdTechSaaS
Earl TaylorJames TaylorCarl TaylorStanford TaylorMark Taylor
Tempo Therapeutics is a biotechnology company developing therapeutics, with a focus that includes dermatology.
BiotechHealthtechMedical DevicesSan Diego, US
Westbrook Weaver(Founder & CEO)inDonald Griffin(Founder & CSO)Stephanie Deshayes(VP R&D)Kwame Ulmer(Chief Regulatory Officer)Philip Scumpia(VP of Medical Affairs, Dermatology)inEric Richman(Executive Officer, Director)in
Co-investorsSugati Ventures
DNA Medicine Institute is a med-tech incubator and biomedical technology innovator that develops diagnostic systems, including its flagship rHEALTH platform, which compresses multiple lab assays into handheld devices validated in clinical, space, and austere environments.
BiotechDeep TechMedical DevicesSpace Tech
Eugene Y. Chan(President and Chief Scientist)
Third Pole develops portable and miniaturized devices that generate inhaled nitric oxide on-demand for hospital and mobile treatment of severe cardiopulmonary diseases and lung infections.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesWaltham, US
Elizabeth Holmberg(CFO and Treasurer)Basil Athenson(Chief Executive Officer and President)Bill Athenson(Chief Executive Officer)inGordon Kinder(Chief Financial Officer)Philip Silkoff(Chief Medical Officer)David Zapol(Director)
Co-investorsSaturn PartnersUnorthodox Ventures
FocalCool develops therapeutic hypothermia technology for treating medical conditions through targeted cooling interventions.
BiotechDeep TechHealthtechMedical Devices
Tom Merrill(Co-Founder & CEO)inJennifer Mitchell(Co-Founder & Technical Advisor)inJay Yadav(former Chairman and Co-Founder)in
Unique Mobility Devices develops patented "zero-lifting" mobility devices, the SitAssist One and SitAssist Two, that lift and transfer people from the floor in seated or supine positions without slings or hoists.
HardwareHealthtechMedical DevicesTucson, US
Venebio Group provides data and technology-driven consulting services to pharmaceutical companies, biotechnology firms, medical device manufacturers, and law firms, delivering scientific manuscripts, regulatory submissions, and related documentation.
BiotechData & InfrastructureDigital HealthEnterprise SoftwareHealthtech
Veriskin makes a handheld, AI-powered medical device that assesses suspect skin growths by imaging cutaneous blood flow in real time, delivering results in about two minutes.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Diego, US
Mirianas Chachisvilis(Executive Officer, Director)inKevin Herzberg(Director)inJohn Fitzgibbon(Director)Eugene Tu(Director)Carl Edman(Director)
Co-investorsArieal Southeast Angel PartnersPasadena Angels
ViewPlus manufactures braille embossers and tactile graphics hardware and software to make educational and technical information accessible to blind and visually impaired students and professionals.
EdTechHardwareHealthtechCorvallis, US
John Gardner(Founder)Carolyn Gardner(Co-founder)Dan GardnerSusannah Gardner
VirTech Bio develops OxyBridge, a human-derived hemoglobin-based oxygen carrier (HBOC) intended as a blood substitute for time-critical trauma patients in hemorrhagic shock and for pre-transplant donor organ perfusion.
BiotechHealthtechMedical DevicesBeverly, US
Joseph Tucker(Executive Officer)Matias Vidal(Co-Founder & Executive Chairman)inDallas Hack(CEO & Director, Medical Affairs)inCOL(R) Dallas Hack, MD, MPH(CEO & Director, Medical Affairs)in
A biologics center of excellence focused on developing and delivering medicines to patients, operating as a subsidiary within the Otsuka pharmaceutical group.
AI & Machine LearningBiotechHealthtechMedical Devices
Zachary Shriver(President and Chief Executive Officer)Karthik Viswanathan(Vice President, Research)in
Co-investorsCTI Life Sciences Fund L.P.Cycad Group LLCLux CapitalMRL Ventures Fund
Las Vegas, US
Stephen J. McCormack(Executive Officer, Director, Promoter)
BoardJohn R. Kimberly(Director)John Wyatt(Director)
Vivonics develops mobile physiological monitoring devices, advanced diagnostics, and non-invasive clinical decision support technologies focused on improving human health and wellness.
AI & Machine LearningDeep TechDigital HealthHealthtechMedical Devices
Gordon Hirschman(President and CEO)Michele Pierro(Director of Technology Development)Michael Martell(Director of Business Operations)
Microbiome analysis company using lab science and machine learning to identify markers and interventions.
BiotechSan Francisco, US
John S. Eid, Ph.D.(Executive Officer, Director)Colleen Cutliffe(Executive Officer, Director)James H. Bullard, Ph.D.(Executive Officer)Orville Kolterman, M.D.(Executive Officer)
BoardAdam D'Augelli(Director)inPeter Barton Hutt(Director)
Co-investorsB3 HoldingAME Cloud VenturesKhosla VenturesSequoia CapitalTrue Ventures
Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections.
HealthtechMedical DevicesRoboticsSan Antonio, US
Mark (Tuck) Stibich(Co-founder)Julie Stachowiak(Co-founder)Morris Miller(CEO)inMark "Tuck" Stibich, MHS PHD FIDSA(Founder, Chief Scientific Officer)
Co-investorsBattery VenturesTargeted Technology FundsTectonic VenturesEssex Woodlands Healthcare Partners
Xoran develops point-of-care CT imaging systems and related software for hospitals, clinics, and veterinary practices.
AI & Machine LearningHardwareHealthtechMedical DevicesAnn Arbor, US
Ziteo Medical is developing a handheld, miniaturized intraoperative molecular imaging device that combines molecular imaging, computer vision, and augmented reality to help surgeons locate and remove cancerous tissue.
AI & Machine LearningHealthtechMedical DevicesBerkeley, US
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












































__Twitter.png)

































